Monograph Details
|
|
Dermatological Disorders
> Acne
|
|
SUMYCIN ORAL SUSP |
| Manufacturer |
|
Par Pharmaceutical, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Tetracycline antibiotic. |
| Generic Name |
|
Tetracycline 125mg/5mL; fruit flavor; contains sulfites. |
| Also |
|
• SUMYCIN
|
| Indications |
|
Adjunct in severe acne. |
| Children |
|
Not recommended. |
| Adults |
|
Initially 1g daily in 2–4 divided doses. After improvement: 125–500mg daily. Take with fluids. |
| Precautions |
|
Renal impairment. Asthma (susp). Monitor blood, renal and hepatic function in long-term use. Avoid sun and UV light. Pregnancy, nursing mothers: not recommended. |
| Interactions |
|
Avoid methoxyflurane, photosensitizing agents. May antagonize bactericidal antibiotics. May increase serum digoxin levels. Reduced absorption with antacids, iron, zinc, calcium, magnesium, dairy products, urinary alkalinizers, other multivalent cations. May reduce effectiveness of oral contraceptives. Monitor prothrombin time with oral anticoagulants. |
| Adverse Reactions |
|
Nausea, dizziness, rash, blood dyscrasias, pseudotumor cerebri, photosensitivity, increased BUN, hepatotoxicity. |
| How Supplied |
250mg—100, 1000
500mg—100, 500
Susp—pt |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
